Tue Dec 17 14:50:00 UTC 2024: ## CVS Health Stock Plunges 54% in Three Years, Underperforming Market

**New York, NY** – CVS Health Corporation (NYSE:CVS) has significantly underperformed the market over the past three years, leaving investors with substantial losses. The pharmaceutical giant’s share price has plummeted 54% in that period, a stark contrast to the market’s approximately 32% return. The decline continues, with a 38% drop in the last year alone and a further 19% decrease in the past quarter. Last week saw an additional 17% fall.

While market fluctuations are expected, CVS Health’s earnings per share (EPS) have also decreased at a compound annual rate of 12% over the past three years, lagging behind the share price decline. This suggests that investor sentiment has soured, reflected in the company’s low price-to-earnings ratio of 11.69.

Although insider buying offers a glimmer of positivity, the company’s total shareholder return (TSR) over the last three years stands at -49%, slightly better than the share price return due to dividend payments. However, even including dividends, shareholders are down 35% for the year, while the market is up 29%. Over five years, the total loss for investors is 5% annually.

While some analysts might see this downturn as a buying opportunity, Simply Wall St cautions investors to thoroughly investigate the company’s fundamentals and underlying business performance before making any investment decisions. The article highlights the need to consider factors beyond share price, such as company risks, before investing. This analysis is for informational purposes only and does not constitute financial advice.

Read More